Robert Landry

Robert Landry is a senior executive at Regeneron Pharmaceuticals, Inc., currently serving as the Executive Vice President - Finance & Chief Financial Officer (CFO).12 Here are some key details about his career and background:

Career at Regeneron

Robert Landry joined Regeneron in September 2013 as Senior Vice President, Finance and Chief Financial Officer.2 He was promoted to Executive Vice President - Finance & CFO in March 2020, a position he currently holds.1 In this role, he is responsible for all financial functions of the company, including Controller's, Treasury, Financial Planning, Tax, and Internal Audit.3

Previous Experience

Before joining Regeneron, Landry had an extensive career in the pharmaceutical industry:

• Pfizer: He served as Senior Vice President and Treasurer from October 2012 to August 2013.12
• Wyeth Pharmaceuticals: Prior to Pfizer's acquisition of Wyeth, Landry held various positions including:
  • Treasurer and Principal Corporate Officer (2007-2009)
  • Director of Pharmaceutical Marketing and Sales for Wyeth's Australian affiliate (2006-2007)
  • Chief Financial Officer for Wyeth's Australian and New Zealand affiliates (2004-2006)4

Education

Landry holds a BBA in Accounting from the University of Notre Dame, which he obtained between 1982 and 1986.12

Upcoming Retirement

It's worth noting that Robert Landry is set to retire in February 2024. Christopher Fenimore, the current Senior Vice President, Head of Accounting and Controller at Regeneron, will succeed Landry as CFO upon his retirement.56